Q5098 HCPCS code: Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
Q5098 is the HCPCS Level II code for injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 520 per day on DME suppliers.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2025-07-01 |
| Last action effective | 2026-07-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 520 | Prescribing Information |
| outpatient hospital claims | 520 | Prescribing Information |
| practitioner claims | 520 | Prescribing Information |
What changed for Q5098
- July 2025: Code appears in this HCPCS release
- 2025-07-01: Q5098 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q5098?
Q5098 is the HCPCS Level II code for injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg. Short descriptor: "Inj ustekinumab-srlf, 1 mg".
Does Medicare cover Q5098?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of Q5098 can be billed per day?
520 on DME suppliers; 520 on outpatient hospital claims; 520 on practitioner claims (NCCI medically unlikely edits).
Related Q50 codes
- Q5001 — Hospice or home health care provided in patient's home/residence
- Q5002 — Hospice or home health care provided in assisted living facility
- Q5003 — Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
- Q5004 — Hospice care provided in skilled nursing facility (snf)
- Q5005 — Hospice care provided in inpatient hospital
- Q5006 — Hospice care provided in inpatient hospice facility
- Q5007 — Hospice care provided in long term care facility
- Q5008 — Hospice care provided in inpatient psychiatric facility
- Q5009 — Hospice or home health care provided in place not otherwise specified (nos)
- Q5010 — Hospice home care provided in a hospice facility
- Q5099 — Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q5098
- Watch Q5098 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q5098
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.